Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

Androgens might not be the only major factor in hair loss; other elements could also be important.

Increasing COX-2 in mouse skin causes bigger sebaceous glands and thinner hair, but stopping COX-2 can reverse hair thinning.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Mutations in the enzyme don't significantly change how it binds to its specific substances.

Human placenta extract may promote hair growth by affecting certain lipid compounds.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.

The inhibitor DPP can promote hair growth.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Gypenosides from Gynostemma pentaphyllum were found to have anti-aging effects, increasing skin collagen and reducing wrinkles.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Multiple treatments work best for hair loss.

Finasteride and minoxidil work best together for hair loss.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

PRGF treatment is safer and more effective for hair loss than topical minoxidil.